Technical Analysis for ZGNX - Zogenix, Inc.

Grade Last Price % Change Price Change
grade C 47.22 0.26% 0.12
ZGNX closed down 0.53 percent on Friday, July 12, 2019, on 51 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical ZGNX trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.25%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.25%
Narrow Range Bar Range Contraction 0.25%
NR7 Range Contraction 0.25%
NR7-2 Range Contraction 0.25%
Wide Bands Range Expansion 0.25%
Overbought Stochastic Strength 0.25%
Down 3 Days in a Row Weakness 0.25%
NR7 Range Contraction -0.27%
Wide Bands Range Expansion -0.27%

Older signals for ZGNX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. Its commercial product includes Sumavel DosePro (sumatriptan injection), a delivery system that offers needle-free subcutaneous administration of sumatriptan for the acute treatment of migraine and cluster headache. The company's lead product candidate, Zohydro, a single-entity extended-release hydrocodone, which has completed Phase III clinical trials for the treatment of moderate to severe chronic pain requiring around-the-clock opioid therapy. It is also developing Relday, an injectable formulation of risperidone, which is in a Phase I clinical trial to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers with 13 years of age and older. Zogenix, Inc. markets and sells its Sumavel DosePro to wholesale pharmaceutical distributors and retail pharmacies in the United States. It has a licensing and distribution agreement with Desitin Arzneimittel GmbH to develop and commercialize DosePro in the European Union, Norway, Switzerland, and Turkey. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was founded in 2006 and is headquartered in San Diego, California.
Chemistry Pharmaceutical Pain Schizophrenia Central Nervous System Disorders Morphinans Cell Signaling European Union Neurochemistry Ketones Migraine Bipolar Disorder Hydrocodone Severe Chronic Pain Treatment Of Central Nervous System Disorders Treatment Of Migraine Indoles Retail Pharmacies Triptans
Is ZGNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 62.4
52 Week Low 33.43
Average Volume 545,173
200-Day Moving Average 43.248
50-Day Moving Average 40.7808
20-Day Moving Average 44.3535
10-Day Moving Average 47.862
Average True Range 1.5426
ADX 33.95
+DI 30.7126
-DI 13.2466
Chandelier Exit (Long, 3 ATRs ) 44.5422
Chandelier Exit (Short, 3 ATRs ) 42.4878
Upper Bollinger Band 52.1385
Lower Bollinger Band 36.5685
Percent B (%b) 0.68
BandWidth 35.104332
MACD Line 2.1776
MACD Signal Line 2.0277
MACD Histogram 0.1499
Fundamentals Value
Market Cap 1.17 Billion
Num Shares 24.8 Million
EPS -3.42
Price-to-Earnings (P/E) Ratio -13.77
Price-to-Sales 35.07
Price-to-Book 12.08
PEG Ratio -0.43
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 48.17
Resistance 3 (R3) 48.18 47.83 47.99
Resistance 2 (R2) 47.83 47.56 47.83 47.93
Resistance 1 (R1) 47.47 47.39 47.30 47.46 47.87
Pivot Point 47.12 47.12 47.04 47.12 47.12
Support 1 (S1) 46.76 46.85 46.59 46.75 46.33
Support 2 (S2) 46.41 46.68 46.41 46.27
Support 3 (S3) 46.05 46.41 46.21
Support 4 (S4) 46.04